Memory and Mental Health in Aging
NCT00043589 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200
Last updated 2013-12-05
Summary
This study will evaluate the effectiveness of donepezil (Aricept®) and cognitive training in improving memory performance in elderly adults.
Conditions
- Memory Disorders
Interventions
- DRUG
-
donepezil
- PROCEDURE
-
Memory-training class
Sponsors & Collaborators
-
National Institute of Mental Health (NIMH)
collaborator NIH - lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 55 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2002-06-30
- Primary Completion
- 2006-12-31
- Completion
- 2007-12-31
Countries
- United States
Study Locations
More Related Trials
-
Aricept to Improve Functional Tasks in Vascular Dementia
NCT00457769 ·Status: UNKNOWN ·Phase: PHASE1
-
Preliminary Efficacy and Safety Study of ST101 Plus Aricept in Alzheimer's Disease
NCT00842816 ·Status: COMPLETED ·Phase: PHASE2
-
Neural Correlates In Mild Alzheimer's Disease
NCT00477659 ·Status: COMPLETED ·Phase: PHASE4
-
Corticolimbic Degeneration and Treatment of Dementia
NCT00768261 ·Status: COMPLETED ·Phase: PHASE4
-
Brain Imaging and Mental Disorders of Aging Intervention
NCT00267163 ·Status: COMPLETED ·Phase: PHASE4
-
Donepezil to Treat Dementia in Parkinson's Disease
NCT00030979 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of Cognitive Function as Measured by Repeated Cognitive Measures After 12 Weeks Treatment With Donepezil
NCT01024660 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
A Study of the Efficacy and Safety of Aricept in Patients With Severe Alzheimer's Disease Who Are Living in Skilled Nursing Homes
NCT00630851 ·Status: COMPLETED ·Phase: PHASE3
-
Phase 3 Randomized Placebo Controlled Clinical Trial of Donepezil
NCT02822573 ·Status: COMPLETED ·Phase: PHASE3
-
Safety, Tolerability, and Efficacy of Donepezil (Aricept) in Parkinson' s Disease (PD) Patients With Dementia
NCT01327859 ·Status: COMPLETED ·Phase: PHASE3
-
Memantine for Agitation in Dementia
NCT00371059 ·Status: COMPLETED ·Phase: PHASE4
-
The Evaluation of the Efficacy and Safety of Donepezil Hydrochloride in Subjects With Mild Cognitive Impairment (MCI)
NCT00293176 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Aricept in the Treatment of Severe Alzheimer's Disease
NCT00096473 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of the Safety and Efficacy of Memantine in Moderate to Severe Alzheimer's Disease
NCT00322153 ·Status: COMPLETED ·Phase: PHASE3
-
A Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-355
NCT03802162 ·Status: COMPLETED ·Phase: PHASE1
-
The Use of Memantine for Prevention of Alzheimer's Disease
NCT05063851 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Evaluating The Impact Of Donepezil Hydrochloride (Aricept) On Behavioral And Psychological Symptoms In Patients With Severe Alzheimer's Disease
NCT00711204 ·Status: WITHDRAWN ·Phase: PHASE4
-
Screening and Evaluation of Patients With Signs and Symptoms of Alzheimer's Disease
NCT00955422 ·Status: COMPLETED
-
Memantine Treatment in Alzheimer's Disease Patients
NCT03168997 ·Status: UNKNOWN ·Phase: PHASE4
-
Magnetic Resonance Spectroscopy Study of Memantine in Alzheimer's Disease
NCT00551161 ·Status: COMPLETED ·Phase: PHASE4
-
Octohydroaminoacridine Succinate Tablet for Mild-to-Moderate Alzheimer's Disease
NCT03283059 ·Status: UNKNOWN ·Phase: PHASE3
-
A Bioequivalence Study of Corplex™ Donepezil Transdermal Delivery System Compared to Aricept®
NCT03259958 ·Status: COMPLETED ·Phase: PHASE1
-
Returning Research Results That Indicate Risk of Alzheimer Disease Dementia to Healthy Participants in Longitudinal Studies
NCT04699786 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Donepezil HCl & Cognitive Deficits in Autism
NCT00047697 ·Status: COMPLETED ·Phase: PHASE2
-
The Evaluation and Follow-up of Individuals With Memory Disorder
NCT00001480 ·Status: COMPLETED